UB Paderborn / Katalog / Suche / in CDI

Identification of the Cryptic HLA-I Immunopeptidome

Cancer immunology research, 2020-08, Vol.8 (8), p.1018-1026

2020

Volltextzugriff (PDF)

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

Nature medicine, 2019-12, Vol.25 (12), p.1916-1927

2019

Volltextzugriff (PDF)

The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression

Oncogene, 2020-10, Vol.39 (44), p.6841-6855

2020

Volltextzugriff (PDF)

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

Science (American Association for the Advancement of Science), 2015-10, Vol.350 (6257), p.207-211

2015

Volltextzugriff (PDF)

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

Nature communications, 2017-05, Vol.8 (1), p.15440-15440, Article 15440

2017

Volltextzugriff (PDF)

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

PloS one, 2015-03, Vol.10 (3), p.e0118564

2015

Volltextzugriff (PDF)

Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark

European journal of cancer (1990), 2019-04, Vol.111, p.30-37

2019

Volltextzugriff (PDF)

Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma

Cancer Immunology, Immunotherapy, 2021-07, Vol.70 (7), p.2087-2093

2021

Volltextzugriff (PDF)

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

International journal of cancer, 2013-10, Vol.133 (7), p.1653-1663

2013

Volltextzugriff (PDF)

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

European journal of cancer (1990), 2019-07, Vol.116, p.207-215

2019

Volltextzugriff (PDF)

Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas

Clinical cancer research, 2013-06, Vol.19 (12), p.3143-3152

2013

Volltextzugriff (PDF)

Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease

PloS one, 2015-08, Vol.10 (8), p.e0134518-e0134518

2015

Volltextzugriff (PDF)

Granulocytic myeloid-derived suppressor cells in peripheral blood of patients with cutaneous melanoma

International immunology, 2016-02, Vol.28 (2), p.99-99

2016

Volltextzugriff (PDF)

TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas

Modern pathology, 2014-04, Vol.27 (4), p.502-508

2014

Volltextzugriff (PDF)

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma

PloS one, 2013-11, Vol.8 (11), p.e80354-e80354

2013

Volltextzugriff (PDF)

Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries

Frontiers in oncology, 2021-03, Vol.11, p.621278-621278

2021

Volltextzugriff (PDF)

A preclinical model of cutaneous melanoma based on reconstructed human epidermis

Scientific reports, 2022-09, Vol.12 (1), p.16269-16269, Article 16269

2022

Volltextzugriff (PDF)

Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion

Journal of experimental & clinical cancer research, 2023-07, Vol.42 (1), p.175-175, Article 175

2023

Volltextzugriff (PDF)

Adjuvante Therapie des Melanoms

Die Onkologie, 2023-08, Vol.29 (8), p.671-679

2023

Volltextzugriff (PDF)

Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review

Journal of medical Internet research, 2021-07, Vol.23 (7), p.e20708

2021

Volltextzugriff (PDF)

Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma

Cancers, 2023-11, Vol.15 (23), p.5521

2023

Volltextzugriff (PDF)

Multicenter phase II trial of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab in japanese advanced melanoma patients: Immune resistance remains one of the major efforts in melanoma research

British journal of dermatology (1951), 2024-07

2024

Volltextzugriff (PDF)

miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro

Journal of clinical medicine, 2020-03, Vol.9 (3), p.670

2020

Volltextzugriff (PDF)

Cutting edge: An inactive chromatin configuration at the IL-10 locus in human neutrophils

The Journal of immunology (1950), 2013-03, Vol.190 (5), p.1921-1925

2013

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Identification of the Cryptic HLA-I Immunopeptidome

Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma

The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions

Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma

Comparing artificial intelligence algorithms to 157 German dermatologists: the melanoma classification benchmark

Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma

Vemurafenib reverses immunosuppression by myeloid derived suppressor cells

Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma

Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas

Modulation and Apoptosis of Neutrophil Granulocytes by Extracorporeal Photopheresis in the Treatment of Chronic Graft-Versus-Host Disease

Granulocytic myeloid-derived suppressor cells in peripheral blood of patients with cutaneous melanoma

TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma

Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries

A preclinical model of cutaneous melanoma based on reconstructed human epidermis

Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion

Adjuvante Therapie des Melanoms

Integrating Patient Data Into Skin Cancer Classification Using Convolutional Neural Networks: Systematic Review

Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma

Multicenter phase II trial of plasminogen activator inhibitor-1 inhibitor (TM5614) plus nivolumab in japanese advanced melanoma patients: Immune resistance remains one of the major efforts in melanoma research

Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway

miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro

Cutting edge: An inactive chromatin configuration at the IL-10 locus in human neutrophils

Suchergebnisse filtern